Shares of drug manufacturers rise, but travel shares fall due to new COVID-19 variant

Shares of airlines fell and drug makers rose in premarket trades Friday as investors reacted to new travel bans related to a COVID-19 variant called B.1.1.529 identified in South Africa. The British government has banned flights from South Africa and five other South African countries. The World Health Organization’s technical working group will meet on Friday to discuss the variant. Pfizer
PFE,
-0.37%

advanced with 5.8%, Moderna
mRNA,
-1.08%

achieved 8.7%, Southwest Airlines
LUV,
+0.02%

dropped 7%, American Airlines
AAL,
-0.05%

stock fell 7%; Expedia
EXPE,
-0.80%

decreased by 6.8% and United Airlines
ual,
+0.06%

decreased by 7.6%. Delta Airlines
VALLEY,
+0.40%

lost 7.8%, Norwegian Cruise
NCLH,
+0.31%

gave up 9.6% and Royal Caribbean
RCL,
-0.63%

the stock lost 10%.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *